• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Atricure Inc (NQ: ATRC )

    27.80 -0.24 (-0.86%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 565,316
    Open 28.27
    Bid (Size) 22.08 (5)
    Ask (Size) 30.27 (1)
    Prev. Close 28.04
    Today's Range 27.12 - 28.27
    52wk Range 18.94 - 43.54
    Shares Outstanding 45,882,449
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    AtriCure Receives CE-Mark for the EnCompass® Clamp
    From AtriCure, Inc.
    Via Business Wire
    AtriCure Announces that the First Patient has been Treated with the Revolutionary AtriClip® FLEX-Mini™ Device
    From AtriCure, Inc.
    Via Business Wire

    Performance

    YTD
    -21.29%
    -21.29%
    1 Month
    +7.17%
    +7.17%
    3 Month
    +23.56%
    +23.56%
    6 Month
    -4.43%
    -4.43%
    1 Year
    -35.72%
    -35.72%

    More News

    Read More
    AtriCure Receives Expanded CE-Mark Indication for AtriClip® Devices for the Reduction of Stroke in Patients with Atrial Fibrillation
    From AtriCure, Inc.
    Via Business Wire
    Navigating 6 Analyst Ratings For AtriCure
    Via Benzinga
    ATRC Stock Earnings: AtriCure Meets EPS, Beats Revenue for Q2 2024
    Via InvestorPlace
    AtriCure Reports Second Quarter 2024 Financial Results
    From AtriCure, Inc.
    Via Business Wire
    AtriCure to Participate in the Canaccord Genuity 44th Annual Global Growth Conference
    From AtriCure, Inc.
    Via Business Wire
    Analyst Ratings For AtriCure
    Via Benzinga
    Cracking The Code: Understanding Analyst Reviews For AtriCure
    Via Benzinga
    Key Takeaways From AtriCure Analyst Ratings
    Via Benzinga
    Cracking The Code: Understanding Analyst Reviews For AtriCure
    Via Benzinga
    AtriCure Receives Regulatory Approval to Sell AtriClip® Devices in China
    From AtriCure, Inc.
    Via Business Wire
    AtriCure to Announce Second Quarter 2024 Financial Results
    From AtriCure, Inc.
    Via Business Wire
    Have 20 Bucks? 7 Low-Priced Stocks That Could Double by 2025
    Via InvestorPlace
    Recap: AtriCure Q4 Earnings
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    AtriCure to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference
    From AtriCure, Inc.
    Via Business Wire
    ATRC Stock Earnings: AtriCure Misses EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    AtriCure Reports First Quarter 2024 Financial Results
    From AtriCure, Inc
    Via Business Wire
    AtriCure to Participate in the 2024 Bank of America Securities Healthcare Conference
    From AtriCure, Inc.
    Via Business Wire
    AtriCure Announces Launch of the cryoSPHERE®+ Probe for Post-Operative Pain Management
    From AtriCure, Inc.
    Via Business Wire
    AtriCure to Announce First Quarter 2024 Financial Results
    From AtriCure, Inc.
    Via Business Wire
    AtriCure to Participate in the 23rd Annual Needham Virtual Healthcare Conference
    From AtriCure, Inc.
    Via Business Wire
    Coinbase To Rally Around 45%? Here Are 10 Top Analyst Forecasts For Friday
    Via Benzinga
    AtriCure Reports Fourth Quarter 2023 and Full Year 2023 Financial Results
    From AtriCure, Inc.
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.